Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
February 1, 1993
[Diffuse polycystic bone hemangiomatosis]
O Mejjad, M F Borie, A Daragon, et al.
Annals of the Rheumatic Diseases
|
July 24, 2007
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
F Chopin, P Garnero, A le Henanff, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Rheumatology (Oxford, England)
|
August 11, 2006
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab
T Lequerré, F Jouen, M Brazier, et al.
European Journal of Haematology
|
January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)
O Mejjad, X Le Loët, J P Basuyau, et al.
The European Journal of Medicine
|
October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)
A Daragon, C Humez, C Michot, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne
|
January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]
C Mathiot, B Grosbois, J L Teillaud, et al.
Joint Bone Spine
|
March 10, 2001
Prospective X-ray densitometry and ultrasonography study of the hand bones of patients with rheumatoid arthritis of recent onset
A Daragon, K Krzanowska, O Vittecoq, et al.
Journal of Clinical Immunology
|
July 1, 2008
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients
H Bacquet-Deschryver, F Jouen, M Quillard, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
February 1, 1993
[Diffuse polycystic bone hemangiomatosis]
O Mejjad, M F Borie, A Daragon, et al.
Annals of the Rheumatic Diseases
|
July 24, 2007
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
F Chopin, P Garnero, A le Henanff, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Rheumatology (Oxford, England)
|
August 11, 2006
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab
T Lequerré, F Jouen, M Brazier, et al.
European Journal of Haematology
|
January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)
O Mejjad, X Le Loët, J P Basuyau, et al.
The European Journal of Medicine
|
October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)
A Daragon, C Humez, C Michot, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne
|
January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]
C Mathiot, B Grosbois, J L Teillaud, et al.
Joint Bone Spine
|
March 10, 2001
Prospective X-ray densitometry and ultrasonography study of the hand bones of patients with rheumatoid arthritis of recent onset
A Daragon, K Krzanowska, O Vittecoq, et al.
Journal of Clinical Immunology
|
July 1, 2008
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients
H Bacquet-Deschryver, F Jouen, M Quillard, et al.
Page
of 7